Statement Of Comprehensive Income [Abstract]

Mithra Pharmaceuticals S.A. - Filing #3183196

Concept	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	2020-01-01 to 2020-12-31	2020-01-01 to 2020-12-31	2020-01-01 to 2020-12-31	2020-01-01 to 2020-12-31	2020-01-01 to 2020-12-31
Statement of comprehensive income [abstract]
Profit (loss)	—	—	—	116 875 EUR	116 875 EUR	92 086 EUR	—	92 086 EUR	—	—
Other comprehensive income [abstract]
Components of other comprehensive income that will not be reclassified to profit or loss, net of tax [abstract]
Other comprehensive income, net of tax, gains (losses) from investments in equity instruments	6 508 EUR	—	—	6 508 EUR	—	—	—	4 772 EUR	—	4 772 EUR
Components of other comprehensive income that will be reclassified to profit or loss, net of tax [abstract]
Exchange differences on translation [abstract]
Other comprehensive income, net of tax, exchange differences on translation of foreign operations	—	—	—	—	—	—	—	66,000 EUR	—	66,000 EUR
Cash flow hedges [abstract]
Other comprehensive income, net of tax, cash flow hedges	10 792 EUR	—	—	10 792 EUR	—	—	—	7 838 EUR	—	7 838 EUR
Other comprehensive income	—	—	—	17 300 EUR	—	—	—	3 000 EUR	—	—
Comprehensive income	17 300 EUR	- EUR	- EUR	134 175 EUR	116 875 EUR	92 086 EUR	- EUR	89 086 EUR	- EUR	3 000 EUR
Comprehensive income attributable to [abstract]
Comprehensive income, attributable to owners of parent	—	—	—	134 175 EUR	—	—	—	89 086 EUR	—	—
Comprehensive income, attributable to non-controlling interests	—	—	—	- EUR	—	—	—	- EUR	—	—